Protocol for Psychopharmacologic Management of Behavioral Health Comorbidity in Adult Patients with Diabetes and Soft Tissue Infections in a Tertiary Care Hospital Setting

• Published in: Advances in skin & wound care Vol. 29; no. 11; p. 518
• Main Authors: Pinkhasov, Aaron, Singh, Deepan, Kashan, Benjamin, DiGregorio, Julie, Criscitelli, Theresa M, Gorenstein, Scott, Brem, Harold
• Format: Journal Article
• Language: English
• Published: United States 01.11.2016
• Subjects: Adult; Aged; Anxiety - diagnosis; Anxiety - drug therapy; Anxiety - epidemiology; Cognition Disorders - diagnosis; Cognition Disorders - drug therapy; Cognition Disorders - epidemiology; Cohort Studies; Comorbidity; Depression - diagnosis; Depression - drug therapy; Depression - epidemiology; Diabetes Complications - diagnosis; Diabetes Complications - drug therapy; Diabetes Complications - psychology; Diabetic Foot - epidemiology; Diabetic Foot - physiopathology; Diabetic Foot - therapy; Disease Management; Female; Humans; Incidence; Male; Mental Disorders - diagnosis; Mental Disorders - drug therapy; Mental Disorders - epidemiology; Middle Aged; Prognosis; Psychopharmacology; Retrospective Studies; Risk Assessment; Severity of Illness Index; Skin Ulcer - epidemiology; Skin Ulcer - physiopathology; Skin Ulcer - therapy; Soft Tissue Infections - diagnosis; Soft Tissue Infections - drug therapy; Soft Tissue Infections - epidemiology; Tertiary Care Centers; Treatment Outcome; United States; Wound Healing - physiology
• ISSN: 1538-8654
• DOI: 10.1097/01.ASW.0000499601.57987.48

To provide information about the effect of psychiatric comorbidities on wound healing in patients with diabetes mellitus (DM). This continuing education activity is intended for physicians, physician assistants, nurse practitioners, and nurses with an interest in skin and wound care. After participating in this educational activity, the participant should be better able to:1. Discuss the connection between DM and the development of psychiatric comorbidities.2. Identify the drugs recommended in the treatment of these psychiatric comorbidities.3. List cautions and contraindications related to the drugs discussed. In patients with diabetes mellitus type 2, psychiatric comorbidities such as depressive and anxiety disorders are 60% or more prevalent than in the general population. The severity of mental illness and the duration of diabetes have been shown to correlate with worsening glycemic control, thus impeding wound healing. A retrospective chart review was conducted in all patients with diabetes mellitus admitted to the wound service with prior or current psychiatric symptoms of anxiety, depression, or cognitive impairment. A psychopharmacologic protocol was developed based on the clinical data collected and treatment parameters used by the behavioral health consultation liaison service.